Sign in or create an account to add this stock to your watchlist.
About DarioHealth (NASDAQ:DRIO)
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. It offers Dario Engage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications, and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy and distributors; and through e-stores. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:DRIO
CUSIPN/A
Phone972-4770-4055
Debt
Debt-to-Equity RatioN/A
Current Ratio3.71
Quick Ratio3.33
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$5.17 million
Price / Sales5.15
Cash FlowN/A
Price / CashN/A
Book Value$0.44 per share
Price / Book3.61
Profitability
EPS (Most Recent Fiscal Year)($1.64)
Net Income$-15,740,000.00
Net Margins-374.45%
Return on Equity-414.86%
Return on Assets-269.39%
Miscellaneous
Employees48
Outstanding Shares16,740,000
DarioHealth (NASDAQ:DRIO) Frequently Asked Questions
What is DarioHealth's stock symbol?
DarioHealth trades on the NASDAQ under the ticker symbol "DRIO."
How were DarioHealth's earnings last quarter?
DarioHealth (NASDAQ:DRIO) released its earnings results on Tuesday, May, 15th. The company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.01. The company earned $1.76 million during the quarter. DarioHealth had a negative net margin of 374.45% and a negative return on equity of 414.86%. View DarioHealth's Earnings History.
When is DarioHealth's next earnings date?
What price target have analysts set for DRIO?
2 analysts have issued 1-year price objectives for DarioHealth's stock. Their forecasts range from $3.50 to $3.50. On average, they expect DarioHealth's share price to reach $3.50 in the next year. View Analyst Ratings for DarioHealth.
Who are some of DarioHealth's key competitors?
Some companies that are related to DarioHealth include Alphatec (ATEC), Restoration Robotics (HAIR), Sensus Healthcare (SRTS), INVO Bioscience (IVOB), Neovasc (NVCN), Invuity (IVTY), Motus GI (MOTS), Arch Therapeutics (ARTH), SANUWAVE (SNWV), iCAD (ICAD), Repro-Med Systems (REPR), Spectral Medical (EDTXF), CAS Medical Systems (CASM), Obalon Therapeutics (OBLN) and Presbia (LENS).
Who are DarioHealth's key executives?
DarioHealth's management team includes the folowing people:
- Mr. Erez Raphael, CEO, Pres & Chairman (Age 45)
- Mr. Zvi Ben David CPA, CFO, Treasurer & Sec. (Age 57)
- Shmuel Herschberg, Marketing Director
Has DarioHealth been receiving favorable news coverage?
Media coverage about DRIO stock has trended somewhat positive on Saturday, according to Accern. Accern identifies negative and positive media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. DarioHealth earned a media sentiment score of 0.11 on Accern's scale. They also assigned news articles about the company an impact score of 45.04 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
How do I buy shares of DarioHealth?
Shares of DRIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is DarioHealth's stock price today?
One share of DRIO stock can currently be purchased for approximately $1.59.
How big of a company is DarioHealth?
DarioHealth has a market capitalization of $26.96 million and generates $5.17 million in revenue each year. The company earns $-15,740,000.00 in net income (profit) each year or ($1.64) on an earnings per share basis. DarioHealth employs 48 workers across the globe.
How can I contact DarioHealth?
DarioHealth's mailing address is 8 HaToKhen Street, Caesarea Industrial Park L3, 3088900. The company can be reached via phone at 972-4770-4055 or via email at [email protected]
MarketBeat Community Rating for DarioHealth (DRIO)
MarketBeat's community ratings are surveys of what our community members think about DarioHealth and other stocks. Vote "Outperform" if you believe DRIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DRIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
DarioHealth (NASDAQ:DRIO) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for DarioHealth in the last 12 months. Their average twelve-month price target is $3.50, suggesting that the stock has a possible upside of 120.13%. The high price target for DRIO is $3.50 and the low price target for DRIO is $3.50. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $3.50 | $3.50 | $5.75 | $5.75 |
| Price Target Upside: | 120.13% upside | 122.93% upside | 302.10% upside | 187.50% upside |
DarioHealth (NASDAQ:DRIO) Consensus Price Target History
DarioHealth (NASDAQ:DRIO) Analyst Ratings History
Show:
(Data available from 5/26/2016 forward)
DarioHealth (NASDAQ:DRIO) Earnings History and Estimates Chart
DarioHealth (NASDAQ DRIO) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/13/2018 | | ($0.20) | | | | | N/A |  |
| 5/15/2018 | Q1 | ($0.19) | ($0.20) | | $1.76 million | View | N/A | |
| 3/19/2018 | Before Market | ($0.28) | ($1.23) | | $1.58 million | View | Listen | |
| 11/14/2017 | Q3 2017 | ($0.29) | ($0.30) | | $1.38 million | View | N/A | |
| 8/14/2017 | 6/30/2017 | ($0.30) | ($0.43) | | $1.21 million | View | N/A | |
| 5/15/2017 | 3/31/2017 | ($0.47) | $0.45 | | $1.01 million | View | N/A | |
| 3/22/2017 | Q4 2016 | | ($0.96) | | $0.84 million | View | N/A | |
| 11/10/2016 | Q316 | ($0.41) | ($0.31) | $0.77 million | $0.73 million | View | N/A | |
| 8/11/2016 | Q2 2016 | ($0.35) | ($0.49) | $0.83 million | $0.67 million | View | N/A | |
| 5/11/2016 | Q1 2016 | ($0.38) | ($0.33) | $0.56 million | $0.57 million | View | N/A | |
| 2/9/2016 | Q4 2015 | | ($0.54) | | $0.31 million | View | N/A | |
| 11/13/2015 | Q3 2015 | | ($0.90) | | $0.27 million | View | N/A | |
| 8/13/2015 | Q2 2015 | | ($1.26) | | $0.18 million | View | N/A | |
| 5/15/2015 | Q1 2015 | | ($1.44) | | $0.07 million | View | N/A | |
| 11/14/2014 | Q3 2014 | ($0.70) | ($0.25) | $0.50 million | | View | N/A | |
| 8/15/2014 | Q2 2014 | ($11.69) | ($14.39) | | | View | N/A | |
| 5/15/2014 | Q1 2014 | ($14.39) | ($12.59) | | | View | N/A | |
| 11/12/2013 | Q3 2013 | ($16.19) | ($15.29) | | | View | N/A | |
| 8/14/2013 | Q2 2013 | ($15.29) | ($14.39) | | | View | N/A | |
| 5/14/2013 | Q1 2013 | | ($15.29) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
DarioHealth (NASDAQ:DRIO) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
DarioHealth (NASDAQ DRIO) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 27.80%
Institutional Ownership Percentage: 1.18%
DarioHealth (NASDAQ DRIO) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/28/2018 | Zvi Ben-David | CFO | Buy | 9,018 | $1.40 | $12,625.20 | | |
| 8/19/2016 | Erez Raphael | CEO | Buy | 500 | $3.57 | $1,785.00 | 111,129 | |
(Data available from 1/1/2013 forward)
DarioHealth (NASDAQ DRIO) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | DarioHealth to Present at Chardan's Digital Health Conference
finance.yahoo.com - May 21 at 4:17 PM |
 | DarioHealth's (DRIO) CEO Erez Raphael on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 4:34 PM |
 | DarioHealth (DRIO) Announces Earnings Results, Misses Expectations By $0.01 EPS
www.americanbankingnews.com - May 15 at 11:59 AM |
| DarioHealth misses by $0.01, beats on revenue
seekingalpha.com - May 15 at 10:20 AM |
| DarioHealth Reports First Quarter 2018 Results
finance.yahoo.com - May 15 at 10:20 AM |
| DarioHealth Releases Next Generation Version 4.0 of its Award-Winning App
finance.yahoo.com - May 8 at 9:36 AM |
| DarioHealth (DRIO) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - May 8 at 2:44 AM |
| DarioHealth (DRIO) Raised to Hold at ValuEngine
www.americanbankingnews.com - May 3 at 10:54 PM |
| DarioHealth to Host First Quarter 2018 Conference Call on May 15, 2018
finance.yahoo.com - May 2 at 9:36 AM |
| DarioHealth Ramps up Commercialization Capabilities
finance.yahoo.com - April 30 at 9:54 AM |
 | BRIEF-Dariohealth Corp Says Selling Stockholders May Offer From Time To Time Up To 8.5 Mln shares
www.reuters.com - April 27 at 10:15 AM |
 | Analyst Actions: Chardan Initiates Coverage on DarioHealth With Buy Rating and $4 PT
www.nasdaq.com - April 9 at 4:14 PM |
| Chardan Capital Initiates Coverage on DarioHealth (DRIO)
www.americanbankingnews.com - April 9 at 8:12 AM |
| DarioHealth, New Glucose Monitoring System, Climbing Revenue, and Analysts Target
finance.yahoo.com - April 4 at 5:17 PM |
| DarioHealth Launches Customer Hotline to Pre-Order Its Apple iPhone Lightning-Compatible Glucose Monitor in the U.S.
finance.yahoo.com - March 29 at 10:08 AM |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of DarioHealth Corp.
finance.yahoo.com - March 27 at 10:10 AM |
 | DarioHealth (DRIO) Announces FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter
www.streetinsider.com - March 26 at 4:09 PM |
| DarioHealth receives U.S. FDA clearance for iPhone 7, 8 and Iphone X Smart Glucose Meter; shares ahead 34% premarket
seekingalpha.com - March 26 at 10:11 AM |
| DarioHealth stock soars after iPhone-compatible glucose monitor receives FDA clearance
finance.yahoo.com - March 26 at 10:11 AM |
| DarioHealth Receives U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter
finance.yahoo.com - March 26 at 10:11 AM |
| ValuEngine Upgrades DarioHealth (DRIO) to "Sell"
www.americanbankingnews.com - March 25 at 6:58 PM |
| DarioHealth (DRIO) Announces Earnings Results, Misses Expectations By $0.95 EPS
www.americanbankingnews.com - March 19 at 1:49 PM |
| Are Earnings Prospects Improving For Loss-Making DarioHealth Corp’s (NASDAQ:DRIO)?
finance.yahoo.com - March 19 at 9:53 AM |
| DarioHealth Reports Fourth Quarter and Year End 2017 Results
finance.yahoo.com - March 19 at 9:53 AM |
| DarioHealth Announces Revised Date for Fourth Quarter and Year End 2017 Conference Call
finance.yahoo.com - March 14 at 10:46 AM |
| DarioHealth to Host Fourth Quarter and Year End 2017 Conference Call on March 20, 2018
finance.yahoo.com - March 8 at 10:07 AM |
| DarioHealth Presents Dario Engage Vision at the HIMSS Annual Conference & Exhibition
finance.yahoo.com - March 5 at 9:59 AM |
| DarioHealth Corp (DRIO) CFO Zvi Ben-David Acquires 9,018 Shares
www.americanbankingnews.com - March 2 at 7:34 PM |
| BRIEF-Dariohealth Launches Sales Of Dario Blood Glucose Monitoring System On Amazon Prime
www.reuters.com - February 20 at 4:38 PM |
| DarioHealth Launches Sales of Dario™ Blood Glucose Monitoring System on Amazon Prime
finance.yahoo.com - February 20 at 9:16 AM |
| DarioHealth Partners With a Leading Diabetes Clinic
finance.yahoo.com - February 12 at 4:42 PM |
| DarioHealth Wins Key Contract Ensuring Its Platform to be Utilized in Clinical Study
finance.yahoo.com - February 8 at 9:03 AM |
| dynaCERT Appoints Colonel Yalon Farhi as Director, Provides Corporate Update Including Equity Financing and Note Redemption
finance.yahoo.com - January 31 at 9:11 AM |
| DarioHealth Introduces iPhone 7, iPhone 8, and iPhone X Compatible Smart Glucose Meter to the Australian Market
finance.yahoo.com - January 17 at 9:57 AM |
| DarioHealth Begins Selling iPhone 7, iPhone 8, and iPhone X Smart Glucose Meter in the U.K.
finance.yahoo.com - January 8 at 9:22 AM |
| What You Must Know About DarioHealth Corp’s (NASDAQ:DRIO) Major Investors
finance.yahoo.com - December 27 at 8:35 PM |
| DarioHealth Granted Another U.S. Patent Strengthening its Core Technology
finance.yahoo.com - December 27 at 3:34 PM |
| Aegis Reaffirms "Buy" Rating for DarioHealth (DRIO)
www.americanbankingnews.com - December 25 at 12:40 AM |
| DarioHealth Gains Regulatory Approval in Australia for iPhone 7, iPhone 8, and iPhone X Smart Glucose Meter
finance.yahoo.com - December 18 at 10:23 AM |
| Does Zero-Debt Make DarioHealth Corp (DRIO) A Financially Strong Company?
finance.yahoo.com - December 9 at 10:03 AM |
| Should You Be Content With DarioHealth Corp’s (DRIO) 55.7% Earnings Growth?
finance.yahoo.com - November 30 at 4:49 PM |
| DarioHealth Corp. :DRIO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 10:09 AM |
| DarioHealth Launches Version 3.5 of its MyDario App to Support iPhone 7 and iPhone 8
finance.yahoo.com - November 20 at 9:09 AM |
| DarioHealth's (DRIO) CEO Erez Raphael on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 14 at 6:27 PM |
| DarioHealth Corp. to Host Earnings Call
finance.yahoo.com - November 14 at 6:27 PM |
| DarioHealth Reports Third Quarter 2017 Results
finance.yahoo.com - November 14 at 6:27 PM |
| What Can We Expect for DarioHealth Corp (DRIO) Moving Forward?
finance.yahoo.com - November 14 at 6:27 PM |
| Investor Network Invites You to the DarioHealth Third Quarter 2017 Earnings Conference Call and Webcast Live on Tuesday, November 14, 2017
finance.yahoo.com - November 13 at 6:38 PM |
| DarioHealth to Host Third Quarter Conference Call on November 14, 2017
finance.yahoo.com - November 6 at 7:27 PM |
| DarioHealth Corp. (DRIO) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - November 1 at 4:28 AM |
DarioHealth (NASDAQ:DRIO) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
DarioHealth (NASDAQ DRIO) Stock Chart for Saturday, May, 26, 2018
Loading chart…
